An official website of the United States government Here’s how you know

COVID-19 is an emerging, rapidly evolving situation • Latest public health information from CDC • Latest research
information from NIH

COVID-19 Treatment Guidelines Search

About the Guidelines Overview Management Therapies Special Populations

Antiviral Therapy Sign Up For Updates

These sections summarize the data on ritonavir-boosted nirmatrelvir, remdesivir, and Email Address
other antiviral medications.
example@domain.com

Submit

Antiviral Therapy Remdesivir Ritonavir-Boosted

Summary Nirmatrelvir Follow Us On Twitter
Remdesivir is a nucleotide
Recommendations (Paxlovid) Our Twitter account has
analogue prodrug that is
the latest news and
Review the Panel’s approved to treat COVID-19 Read about using ritonavir-
updates about the
recommendations on the in certain patients. boosted nirmatrelvir in
Treatment Guidelines.
use of antiviral therapies in patients with COVID-19.

patients with COVID-19.

Molnupiravir Interferons Ivermectin

Read about using Interferons are a group of Ivermectin is an

molnupiravir in patients antiviral cytokines that are antiparasitic drug that is

with COVID-19. being evaluated to treat being evaluated to treat

COVID-19. COVID-19.

Table:
Characteristics of
Antiviral Agents

This table summarizes key

characteristics of antiviral

agents that have been

evaluated for COVID-19.

www.covid19treatmentguidelines.nih.gov

An ofDcial website of the National Institutes of Health

Contact Us About NIH Freedom of Information Act No FEAR Act Data

OfSce of Inspector General NIH Performance Reporting Web Policies and Notices Vulnerability Disclosure
Policy
Looking for U.S. government information and services? Visit USA.gov Site Updated: August 18, 2022

Original text
Contribute a better translation